Use of Mass Spectrometry to Assist Production of SARS-CoV-2 Spike Protein Characterisation

Use of Mass Spectrometry to Assist Production of SARS-CoV-2 Spike Protein Characterisation

Published on 16/08/2021
Use of Mass Spectrometry to Assist Production of SARS-CoV-2 Spike Protein Characterisation

Peak Proteins - read the recently published Sciex COVID Technote written in collaboration with Sciex.

Peptide mapping analysis of COVID-19 spike protein using the SCIEX X500B QTOF System and Protein Metrics Inc. software enables the confirmation of induced protein variants.

Authors:

Raquel Faba-Rodriguez and Rachel Rowlinson from Peak Proteins and

Sibylle Heidelberger, Chris Nortcliffe and Stephen Lock from SCIEX, UK

Abstract:

In this work, mass spectrometry has been used in assessing purity during protein production experiments. Both wild type (WT) and mutant forms of SARS-CoV-2 spike protein were expressed in a HEK293 system and were confirmed by analysis with the SCIEX X500B System. Rapid and efficient characterization was performed by using automated data analysis with Byos software (Protein Metrics Inc.).

Download PDF here

Our Valued Sponsors & Partners